067630 (HLB Life Science Co Ltd) vs KOSPI 200 Comparison

067630

KOSPI 200

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

067630

KOSPI 200

Difference

1Y 3Y 5Y 10Y 15Y 20Y

067630

KOSPI 200

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

KOSPI 200

067630

MCK

COR

0HF3

CAH

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

HLB Life Science Co Ltd
Glance View

Market Cap

1.3T KRW

Industry

Health Care

HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-11-25. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. The company is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.

View HLB Life Science Co Ltd Analysis

Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US		Mckesson Corp NYSE:MCK	Select
US		Cencora Inc NYSE:COR	Select
US	A	Amerisourcebergen Corp LSE:0HF3	Select
US		Cardinal Health Inc NYSE:CAH	Select
US		Henry Schein Inc NASDAQ:HSIC	Select
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Select
CN		Sinopharm Group Co Ltd HKEX:1099	Select
CN		Huadong Medicine Co Ltd SZSE:000963	Select
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Select
IT		Amplifon SpA MIL:AMP	Select

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

HR	C	CROBEX INDX:CRBEX	Add
SA	T	Tadawul All Share INDX:TASI	Add
TH	S	SET Index INDX:SET	Add
ID	J	Jakarta Composite Index INDX:JKSE	Add
GR	A	Athens General Composite INDX:ATG	Add
BR	B	BOVESPA INDX:BVSP	Add
AR	S	S&P Merval INDX:MERV	Add
MX	M	Mexico S&P/BMV IPC INDX:MXX	Add
CZ	P	PX Prague Stock Index INDX:PX	Add
RU	M	MOEX Russia INDX:IMOEX	Add

	Franklin Covey Co NYSE:FC	31.07 USD -11.98%
	Mohawk Industries Inc NYSE:MHK	118.265 USD -0.01%
	Ardmore Shipping Corp NYSE:ASC	13.35 USD 6.29%
	ASGN Inc NYSE:ASGN	85.29 USD -1.88%
	Skyworks Solutions Inc NASDAQ:SWKS	91.32 USD -1.41%
	Weatherford International PLC NASDAQ:WFRD	71.09 USD -1.44%

067630

vs

KOSPI 200

Stocks Performance
067630 vs KOSPI 200

Performance Gap
067630 vs KOSPI 200

Performance By Year
067630 vs KOSPI 200

Competitors Performance
HLB Life Science Co Ltd vs Peers

HLB Life Science Co Ltd
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	142.7 USD 0.3%
	Bank of America Corp NYSE:BAC	45.08 USD -2.45%
	Mastercard Inc NYSE:MA	505.45 USD -2.12%
	Salesforce Inc NYSE:CRM	320.35 USD -2%
	Abbvie Inc NYSE:ABBV	176.24 USD -1.27%
	Home Depot Inc NYSE:HD	389.425 USD 0.57%

	Arista Networks Inc NYSE:ANET	114.65 USD -0.74%
	Visa Inc NYSE:V	307.36 USD -1.68%
	Texas Pacific Land Corp NYSE:TPL	1 296.175 USD 1.59%
	KLA Corp NASDAQ:KLAC	679.71 USD -0.95%
	Manhattan Associates Inc NASDAQ:MANH	266.375 USD -2.24%
	Pinduoduo Inc NASDAQ:PDD	95.33 USD -4.97%

	Salesforce Inc NYSE:CRM	320.35 USD -2%
	ServiceNow Inc NYSE:NOW	1 032.14 USD -1.61%
	EOG Resources Inc NYSE:EOG	130.76 USD 1.79%
	Copart Inc NASDAQ:CPRT	55.86 USD -1.62%
	Applied Materials Inc NASDAQ:AMAT	170.99 USD -3.39%
	Synopsys Inc NASDAQ:SNPS	489.74 USD -2.44%

	Johnson & Johnson NYSE:JNJ	142.7 USD 0.3%
	Berkshire Hathaway Inc NYSE:BRK.A	664 785.26 USD -1.94%
	Bank of America Corp NYSE:BAC	45.08 USD -2.45%
	Mastercard Inc NYSE:MA	505.45 USD -2.12%
	UnitedHealth Group Inc NYSE:UNH	524.58 USD 0.01%
	Exxon Mobil Corp NYSE:XOM	106.62 USD -0.29%

067630 vs KOSPI 200

Stocks Performance 067630 vs KOSPI 200

Performance Gap 067630 vs KOSPI 200

Performance By Year 067630 vs KOSPI 200

Competitors Performance HLB Life Science Co Ltd vs Peers

HLB Life Science Co Ltd Glance View

Company

Help

Tools

Stocks

067630

vs

KOSPI 200

Stocks Performance
067630 vs KOSPI 200

Performance Gap
067630 vs KOSPI 200

Performance By Year
067630 vs KOSPI 200

Competitors Performance
HLB Life Science Co Ltd vs Peers

HLB Life Science Co Ltd
Glance View